Endocrine-disrupting chemical exposure in womb impact fear, anxiety behavior in rats
Prenatal exposure to endocrine-disrupting chemicals found in everyday products may interfere with the developing offspring’s brain, according to a rat study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta,...
– Endocrine Society | 07-Jun-2022 03:05 PM EDT
» ENDO 2022, June-2022 (Meeting)

Chemicals in personal care products cause harmful effects in breast cancer cells from Black women
Chemicals called parabens, which are found in widely used hair and personal care products, cause harmful effects in breast cancer cells from Black women, according to a new study being presented Sunday at ENDO 2022, the Endocrine Society’s annual...
– Endocrine Society | 07-Jun-2022 03:05 PM EDT
» ENDO 2022, June-2022 (Meeting)

Bias may play a role in underdiagnoses of prediabetes
The accurate diagnosis of prediabetes in the primary care setting might depend on a patient’s age, BMI, gender, race and certain comorbidities, according to research being presented at ENDO 2022, the Endocrine Society’s annual meeting in...
– Endocrine Society | 07-Jun-2022 01:05 PM EDT
» ENDO 2022 (Meeting)

AI can be used to identify benign thyroid nodules and reduce unnecessary biopsies
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies, according to a new study being presented Saturday at ENDO 2022,...
– Endocrine Society | 07-Jun-2022 01:05 PM EDT
» ENDO 2022, June-2022 (Meeting)

Researchers develop pancreatic beta-cell restoring therapy for treating type 1 diabetes
Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to treat the human condition...
– Endocrine Society | 07-Jun-2022 12:05 PM EDT
» ENDO 2022 (Meeting)

Drinking coffee does not hinder the absorption of liquid thyroid medication
A new study conducted by Vertice Pharma confirms the absorption of an oral levothyroxine sodium solution (Thyquidity® 100g/ 5mL) was not affected by consuming coffee 5 minutes after the dose, according to research being presented Saturday at...
– Endocrine Society | 07-Jun-2022 11:05 AM EDT
» ENDO 2022, June-2022 (Meeting)

COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism, according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not...
– Endocrine Society | 07-Jun-2022 10:05 AM EDT
» ENDO 2022, June-2022 (Meeting)

Teens ate less ultra-processed food consumption during pandemic, reversing trend of three decades
For the first time in the last 30 years, the consumption of ultra-processed foods among teenagers in the United States declined during the COVID-19 pandemic, according to a new study presented at ENDO 2022, the Endocrine Society’s annual meeting...
– Endocrine Society | 07-Jun-2022 10:05 AM EDT
» ENDO 2022, June-2022 (Meeting)

Probiotic bacteria may enhance tamoxifen effectiveness in treatment of ER+ breast cancer
Probiotic bacteria may enhance anti-cancer activities of the breast cancer drug tamoxifen and other endocrine-targeted therapies, which could help reduce the risk of estrogen receptive positive (ER+) breast cancer, suggests a new study presented...
– Endocrine Society | 07-Jun-2022 10:05 AM EDT
» ENDO 2022, June-2022 (Meeting)

Adult growth hormone deficiency increases medical costs, risk of additional health conditions
Growth hormone deficiency (GHD) among adults is associated with greater medical costs and an increased rate of other health conditions compared with those without GHD, according to industry-sponsored research being presented Monday at ENDO 2022, the...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

Empagliflozin may decrease risk of kidney stones in people with diabetes
The diabetes drug empagliflozin may decrease the risk of kidney stones in patients with type 2 diabetes, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Journal)

Testosterone improves quality of life, sexual function, and delayed verbal recall in men with uncontrolled type 2 diabetes
Testosterone replacement therapy improved sexual symptoms, libido, symptom severity, delayed verbal recall and overall quality of life among people with poorly controlled type 2 diabetes and hypogonadism, according to research being presented Monday...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

Addressing stress and postpartum symptoms early may reduce risk for type 2 diabetes in women with gestational diabetes
Addressing stress early on in postpartum women who recently experienced gestational diabetes might help curb an increased risk for type 2 diabetes, according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Journal)

Male runners who are energy deficient may be at higher risk for fractures
Male runners who do not receive enough energy from their diet may be at risk for stress fractures, according to a new study presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Journal)

Maintaining normal weight early in life may help prevent male infertility
New research suggests that more careful control of body weight in childhood and adolescence could help prevent male infertility later in life. The researchers will present their findings on Saturday, June 11 at ENDO 2022, the Endocrine Society’s...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT

Unhealthy diet helps explain association between food insecurity and obesity
There is a greater prevalence of obesity and higher body fat among people who face food insecurity, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

Cost of mental health disorders linked with polycystic ovary syndrome almost $6 billion in 2021
The cost of mental health disorders associated with polycystic ovary syndrome (PCOS) – depression, anxiety and eating disorders – reached almost $6 billion in 2021, according to a new study presented Monday, June 13 at ENDO 2022, the Endocrine...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Journal)

Mouse model of transgender men finds active testosterone worsens IVF outcomes
Active testosterone therapy for transgender men may negatively impact IVF outcomes, suggests a mouse study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

Study links diabetes and worse outcomes in long-term survivors of metastatic breast cancer
Women who are longer-term survivors of metastatic breast cancer may have a worse survival rate if they have diabetes and poorly controlled blood sugar levels, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Moderation may disrupt addictive nature of wireless mobile devices and adverse health outcomes
Encouraging moderation, balance and real-life engagement coupled with education may combat the overuse of wireless mobile devices and subsequent adverse health outcomes, according to research being presented Sunday at ENDO 2022, the Endocrine...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Growth hormone improves liver health in people with nonalcoholic fatty liver disease
Growth hormone improves liver health in patients with nonalcoholic fatty liver disease (NAFLD) by reducing liver fat and inflammation, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Increased fracture risk in patients using insulin compared to metformin
Patients with type 2 diabetes have an increased risk for fractures, despite their normal-to-high bone mineral density, according to research being presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

COVID-19 pandemic stress impacts ovulation
Life disruptions and the stresses of the COVID-19 pandemic led to disturbed ovulation with decreased progesterone durations or levels, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

Study finds disparities in access to insulin pumps among youth with type 1 diabetes
Over the past 20 years, despite the overall increase in the use of insulin pumps, there have been few improvements in the ethnic, racial and socioeconomic inequities in insulin pump use among youth with type 1 diabetes, according to a new study...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

East Coast is home to greatest hot spots for diabetes complications
The East Coast of the United States, especially Florida, and Texas have some of the greatest hot spots for long-term diabetes complications, according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Stem-cell based therapy shows promise in treating high-risk type 1 diabetes
An investigative stem cell-based therapy called PEC-Direct, designed to act as a replacement pancreas, has the potential to provide blood sugar control in patients with high-risk type 1 diabetes, suggests a clinical study presented Saturday, June 11...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Suppressed ovarian follicle development in women with obesity may explain reduced fertility
Women with obesity, even those with regular menstrual cycles, have suppressed ovarian follicle development and reduced production of reproductive hormones, which may underlie reduced fertility, according to a new study being presented Saturday at...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

Study finds long-term 10% weight loss with anti-obesity medications and lifestyle changes
A new study finds overweight and obese people maintained an average weight loss of 10.6% over 3 to 5 years with a program of lifestyle changes in combination with anti-obesity medications. Weight loss of more than 10% provides significant health...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Study finds strong association between prediabetes and heart attack risk
Prediabetes appears to be a strong independent risk factor for heart attacks, according to a new study presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Phase 3 study finds fezolinetant reduces the frequency and severity of menopausal hot flashes
Fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms (VMS), or hot flashes, associated with menopause, according to a Phase 3 industry-sponsored study being presented Saturday at ENDO 2022, the...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

People who consume too much high fructose corn syrup could be at risk for NAFLD
High fructose consumption should be avoided to prevent the development of non-alcoholic fatty liver disease (NAFLD), according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022 (Meeting)

Longer treatment with puberty-delaying medication in transgender youth leads to lower bone mineral density
A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in...
– Endocrine Society | 07-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

Analysis finds little evidence of heart problems in men undergoing testosterone treatment
Previous clinical trials have provided insufficient evidence to decide whether testosterone causes heart problems in men during the first year of treatment, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual...
– Endocrine Society | 06-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)
» Lancet Healthy Longevity, June-2022 (Journal)

Male contraceptive pills show promise in new study
Two experimental male contraceptive pills appear to effectively lower testosterone without causing unacceptable side effects, according to a new study that will be presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta,...
– Endocrine Society | 06-Jun-2022 09:00 AM EDT
» ENDO 2022, June-2022 (Meeting)

“Hunger hormone” ghrelin affects monetary decision making
Higher levels of the stomach-derived hormone ghrelin, which stimulates appetite, predict a greater preference for smaller immediate monetary rewards over larger delayed financial rewards, a new study finds. The study results will be presented at...
– Endocrine Society | 18-Mar-2021 11:50 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Tubeless automated insulin delivery system improves blood glucose outcomes
People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation’s Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy....
– Endocrine Society | 17-Mar-2021 05:05 PM EDT
» ENDO 2021, Mar-2021 (Meeting)

U.S. children from Spanish-speaking households experience higher rate of obesity than those from English-speaking families
Nearly one in five U.S. children and teenagers has obesity, and statistics show a higher prevalence of obesity in certain ethnicities, such as Hispanics and Blacks. Now results of a study being presented at ENDO 2021, the Endocrine Society’s...
– Endocrine Society | 17-Mar-2021 09:05 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

White button mushrooms could slow progression of prostate cancer
The chemicals present in white button mushrooms may slow the progression of prostate cancer, according to a mouse study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Hospitalized COVID-19 patients fare worse when they have high blood sugar
Patients hospitalized with COVID-19 have worse outcomes if they have high blood sugar, or hyperglycemia, regardless of whether they have diabetes, a new study finds. The researchers will present their results, of the first known study of the impact...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Journal)

Children, teens with type 1 diabetes had better glucose control during COVID-19 lockdown
Blood glucose levels improved among children and teens with type 1 diabetes during the first 12 weeks of COVID-19 lockdown in the United Kingdom, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Increased risk of hearing impairment with new thyroid eye disease treatment
More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease, teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021, the...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Journal)

Genetic evidence suggests men can develop PCOS-like condition
New genetic research suggests men can develop characteristics of polycystic ovary syndrome (PCOS)—a common metabolic and reproductive disorder that affects women. The study was presented virtually at ENDO 2021, the Endocrine Society’s annual...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Lifestyle program improves fertility for women with obesity, infertility
A lifestyle intervention targeting women with obesity and infertility is more effective in increasing the pregnancy rate compared with fertility treatments, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

New treatment shows promise in preventing heart failure after heart attack
A study in mice finds treatment with a molecule called MCB-613 repairs heart tissue after a severe heart attack, preventing damage that can lead to heart failure. The findings are being presented virtually at ENDO 2021, the Endocrine Society’s...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Poor diabetes control in children tied to high risk for COVID-19 complications, death
Children with poorly controlled type 1 diabetes have a 10 times higher risk of COVID-19-related complications and death compared to those with well-controlled diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society’s...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Journal)

Black women with PCOS have higher risk factors for heart disease, diabetes and stroke
Black women with polycystic ovary syndrome (PCOS) have higher risk factors for heart disease, diabetes and stroke compared with white women, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Semaglutide reduces excess body fat in people with obesity
In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored study presented virtually...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Children with adrenal insufficiency are 10 times more likely to die from COVID-19
Children with adrenal insufficiency—a condition in which the adrenal gland does not function properly—are at more than 10 times higher risk for COVID-19 complications and death compared with children with normal adrenal glands, according to a...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT

Few patients at risk for common high blood pressure disorder receive screening
Only 3% of patients at high risk for primary aldosteronism (PA), a common disorder that causes high blood pressure and can lead to heart and kidney complications, are screened for the condition, according to a study that will be presented virtually...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Night owls with gestational diabetes may face higher risk of pregnancy complications
Among women who develop diabetes during pregnancy, night owls have a higher risk of complications for mother and baby than early birds do, according to a study whose results will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

High readmission rate found for adults with type 1 diabetes hospitalized for diabetic ketoacidosis
One in five adults with type 1 diabetes who require in-hospital treatment of the life-threatening condition diabetic ketoacidosis has an unplanned repeat hospital visit within a month and is twice as likely to die during the second hospitalization,...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care
People with obesity who are hospitalized with COVID-19 have a significantly higher rate of ICU admissions and longer duration of ICU stay compared to people with a normal body mass index (BMI), according to a study presented virtually at ENDO 2021,...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Obesity raises type 2 diabetes risk in women with PCOS
Women with obesity and polycystic ovarian syndrome (PCOS) are at increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting. Normal-weight women with PCOS are not at...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT

Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity
An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low testosterone levels, with no evidence of liver toxicity....
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Combination thyroid hormone therapies treat hypothyroidism as well as levothyroxine
Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and combination therapy to...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Largest-ever analysis of its kind finds Cushing’s syndrome triples risk of death
Endogenous Cushing’s syndrome, a rare hormonal disorder, is associated with a threefold increase in death, primarily due to cardiovascular disease and infection, according to a study whose results will be presented at ENDO 2021, the Endocrine...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Common drugs for type 2 diabetes and obesity do not increase breast cancer risk
Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, despite previous studies that suggested a possible link, according to...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin
A new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low blood sugar episodes compared with a daily basal insulin, according to a phase 2 clinical trial. The study results, which will be presented at...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Many endocrine patients, providers want to continue telehealth after pandemic
Two-thirds of patients with chronic endocrine health problems who need close monitoring say they would like to continue with telemedicine follow-up visits after the COVID-19 pandemic ends, according to a survey that will be presented virtually at...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Sleep disturbances may contribute to weight gain in menopause
Addressing sleep symptoms during menopause may reduce susceptibility to weight gain, according to a small study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» EMDO 2021 (Meeting)

Transgender youth face higher risk of conditions that affect heart health
Transgender youth have higher odds than cisgender youth of being diagnosed with medical conditions that can affect their overall metabolic and cardiovascular health, according to a study presented virtually at ENDO 2021, the Endocrine Society’s...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021 (Meeting)

Drug used during pregnancy may increase cancer risk in mother’s adult children
Exposure in the womb to a drug used to prevent miscarriage appears to raise the offspring’s cancer risk decades later, especially for colorectal and prostate cancers, researchers have found. They will present the results of their new study Tuesday...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

COVID-19 can cause atypical thyroid inflammation
Some patients with moderate to severe COVID-19 disease seem to experience inflammation of the thyroid gland that is different from thyroid inflammation caused by other viruses, according to a study presented virtually at ENDO 2021, the Endocrine...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

First targeted therapy for children with achondroplasia shows persistent height gain for up to two years
Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored...
– Endocrine Society | 17-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Supplements may protect those with low vitamin D levels from severe COVID-19
Patients with low vitamin D levels who are hospitalized for COVID-19 may have a lower risk of dying or requiring mechanical ventilation if they receive vitamin D supplementation of at least 1,000 units weekly, according to a study presented...
– Endocrine Society | 17-Mar-2021 08:30 AM EDT
» ENDO 2021, Mar-2021 (Meeting)
» Journal of Clinical Endocrinology & Metabolism (Journal)

Osteoporosis drug prescribing often does not follow guidelines
Less than one in 10 commercially insured patients in the United States who broke a hip, a major complication of osteoporosis, receive any osteoporosis medical treatment within two calendar quarters of their fracture, according to a study whose...
– Endocrine Society | 15-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Nearly one-third of older thyroid patients take medications that interfere with thyroid function tests
Nearly one-third of adults age 65 and older who take thyroid hormone also take medications that are known to interfere with thyroid function tests, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
– Endocrine Society | 15-Mar-2021 09:00 AM EDT
» ENDO 2021, Mar-2021 (Meeting)

Eating before 8:30 a.m. could reduce risk factors for type 2 diabetes
People who start eating before 8:30 a.m. had lower blood sugar levels and less insulin resistance, which could reduce the risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual...
– Endocrine Society | 15-Mar-2021 09:00 AM EDT
» ENDO 2021, the Endocrine Society’s annual meeting (Meeting)

Propylparaben exposure during pregnancy, breastfeeding may reduce protection against breast cancer
Low doses of propylparaben—an estrogen-like chemical used as a preservative in personal care products and foods—can alter pregnancy-related changes in the breast in ways that may reduce the normal protection against breast cancer that pregnancy...
– Endocrine Society | 15-Mar-2021 08:05 AM EDT
» Endocrinology, Mar-2021 (Journal)
» ENDO 2021, Mar-2021 (Meeting)

Virtual ENDO 2021 press conferences to highlight emerging COVID-19 research
Researchers will explore how diabetes, obesity and other endocrine conditions impact the course of the COVID-19 pandemic during the Endocrine Society’s ENDO 2021 virtual news conferences March 22-23.
– Endocrine Society | 10-Mar-2021 09:00 AM EST
» ENDO 2021 (Meeting)

Obesity may affect puberty timing and hormones in girls
Puberty looks different, in terms of both reproductive hormones and breast maturation, in girls with excess total body fat, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
– Endocrine Society | 25-Feb-2021 09:00 AM EST
» Journal of Clinical Endocrinology & Metabolism (Journal)
» ENDO 2021 (Meeting)

Abnormal sodium levels in hospitalized patients with COVID-19 predict death or respiratory failure
Hospitalized patients with COVID-19 and abnormal sodium levels in the blood have an increased risk of experiencing respiratory failure or dying, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology &...
– Endocrine Society | 24-Feb-2021 02:55 PM EST
» Journal of Clinical Endocrinology & Metabolism (Journal)
» ENDO 2021 (Meeting)

Study finds risk factor for blood clots occurs in more than 10 percent of transgender men using testosterone
A potentially dangerous side effect of testosterone therapy for transgender men is an increase in red blood cells that can raise the risk of blood clots, heart attack or stroke, according to a new study published in the Endocrine Society’s Journal...
– Endocrine Society | 15-Feb-2021 09:00 AM EST
» Journal of Clinical Endocrinology & Metabolism (Journal)
» ENDO 2021 (Meeting)

Media registration open for ENDO 2021
Members of the media can now register to cover the latest advances in hormone health and science at ENDO 2021, the Endocrine Society’s virtual annual meeting being held March 20-23, 2021 in a state-of-the-art digital platform. The virtual meeting...
– Endocrine Society | 18-Nov-2020 02:40 PM EST
» ENDO 2021 (Meeting)

Endocrine Society shifts ENDO 2021 to virtual format
The Endocrine Society will switch its annual meeting, ENDO 2021, to a fully virtual format, the Society announced today.
– Endocrine Society | 17-Sep-2020 01:30 PM EDT
» ENDO 2021 (Meeting)